why choose us

First received: January 07, 2024

Clinical Trial: Mass Balance of Orally Administered [14C] (3S,4S,5R)-1,3,4,5,6-pentahydroxy-hexan-2-one

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Energy Intake

Study Type: INTERVENTIONAL


Official Title: Assessment of Mass Balance of Orally Administered [14C] (3S,4S,5R)-1,3,4,5,6-pentahydroxy-hexan-2-one in Healthy Volunteers Using a Microtracer Approach

Brief Summary: Worldwide almost 40% of the adult population is overweight (including >10% obese), and more than 350 million children (up to the age of 19) are overweight.Overweight and obesity are significant problems and important risk factors for several lifestyle-related diseases, such as cardiovascular disease, certain cancers, non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D).Excessive consumption of glucose/sucrose is a major contributor to overweight and obesity.Alternative, low-calorie…

Read more